Verastem(VSTM)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

VSTM Verastem

盘前交易 05-19 06:31:00 EDT

4.26

-0.06

-1.39%

盘前4.28

+0.02+0.42%

06:16 EDT

最高4.37	最低4.23	成交量166.47万
今开4.31	昨收4.32	日振幅3.24%
总市值3.74亿	流通市值3.20亿	总股本8,784万
成交额713.78万	换手率2.22%	流通股本7,506万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"VSTM","market":"US","secType":"STK","nameCN":"Verastem","latestPrice":4.26,"timestamp":1779134400000,"preClose":4.32,"halted":0,"volume":1664747,"hourTrading":{"tag":"盘前","latestPrice":4.2778,"preClose":4.26,"latestTime":"06:16 EDT","volume":1264,"amount":5434.154672,"timestamp":1779185801404,"change":0.0178,"changeRate":0.004178,"amplitude":0.046948},"delay":0,"changeRate":-0.013888888888889003,"floatShares":75061500,"shares":87835106,"eps":-2.414264,"marketStatus":"盘前交易","change":-0.06,"latestTime":"05-19 06:31:00 EDT","open":4.31,"high":4.37,"low":4.23,"amount":7137792.5436579995,"amplitude":0.032407,"askPrice":4.98,"askSize":90,"bidPrice":4.11,"bidSize":178,"shortable":3,"etf":0,"ttmEps":-2.414264,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1779197400000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1327640400000,"exchange":"NASDAQ","adjPreClose":4.26,"preHourTrading":{"tag":"盘前","latestPrice":4.2778,"preClose":4.26,"latestTime":"06:16 EDT","volume":1264,"amount":5434.154672,"timestamp":1779185801404,"change":0.0178,"changeRate":0.004178,"amplitude":0.046948},"postHourTrading":{"tag":"盘后","latestPrice":4.22,"preClose":4.26,"latestTime":"19:48 EDT","volume":34053,"amount":145057.67,"timestamp":1779148091537,"change":-0.04,"changeRate":-0.00939,"amplitude":0.00939},"volumeRatio":0.7417886444884094,"impliedVol":1.2214,"impliedVolPercentile":0.584},"requestUrl":"/m/hq/s/VSTM","defaultTab":"news","newsList":[{"id":"1136532289","title":"Verastem Oncology公布Avmapki®与Fakzynja®联合疗法（Avutometinib胶囊；Defactinib片剂）治疗复发性低级别浆液性卵巢癌的两年中位随访数据，亮相2026年SGO女性癌症年会","url":"https://stock-news.laohu8.com/highlight/detail?id=1136532289","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136532289?lang=zh_cn&edition=full","pubTime":"2026-04-10 19:01","pubTimestamp":1775818900,"startTime":"0","endTime":"0","summary":"Verastem Oncology在2026年妇科肿瘤学会（SGO）女性癌症年度会议上，公布了其Avmapki®与Fakzynja®联合疗法（即Avutometinib胶囊与Defactinib片剂）用于治疗复发性低级别浆液性卵巢癌的两年中位随访数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611112240","title":"Verastem, Inc.盘中异动 早盘快速拉升5.39%报6.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2611112240","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611112240?lang=zh_cn&edition=full","pubTime":"2026-02-13 23:45","pubTimestamp":1770997553,"startTime":"0","endTime":"0","summary":"北京时间2026年02月13日23时45分，Verastem, Inc.股票出现异动，股价急速上涨5.39%。截至发稿，该股报6.16美元/股，成交量40.006万股，换手率0.53%，振幅3.89%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为2.01%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213234554a6f84ca4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260213234554a6f84ca4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608989853","title":"Verastem, Inc.盘中异动 早盘急速上涨5.24%报6.63美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2608989853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608989853?lang=zh_cn&edition=full","pubTime":"2026-02-04 22:36","pubTimestamp":1770215778,"startTime":"0","endTime":"0","summary":"北京时间2026年02月04日22时36分，Verastem, Inc.股票出现波动，股价大幅上涨5.24%。截至发稿，该股报6.63美元/股，成交量25.455万股，换手率0.34%，振幅3.49%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223618a47c5451&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260204223618a47c5451&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176027781","title":"Verastem计划于2026年上半年与FDA会晤，共商胰腺癌、非小细胞肺癌及结直肠癌新药开发路径与注册导向临床试验方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1176027781","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176027781?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:38","pubTimestamp":1770208708,"startTime":"0","endTime":"0","summary":"生物制药公司Verastem近日披露，将于2026年上半年与美国食品药品监督管理局（FDA）展开正式对话，旨在明确其创新疗法的后续开发策略。此次会议将重点探讨针对胰腺癌（PDAC）、非小细胞肺癌（NSCLC）及结直肠癌（CRC）等实体瘤的潜在注册导向型临床试验设计框架。这一关键步骤标志着公司核心研发项目向商业化迈进的重要节点，也为未来加速创新疗法上市奠定监管基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158305584","title":"Verastem预计LGSC商业化上市及开发项目将于2026年下半年实现自给自足","url":"https://stock-news.laohu8.com/highlight/detail?id=1158305584","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158305584?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:33","pubTimestamp":1770208405,"startTime":"0","endTime":"0","summary":"生物制药公司Verastem近日宣布，其针对低级别浆液性卵巢癌的创新疗法商业化进程取得重大进展。公司预计，该项目的全面上市与后续研发计划最晚将于2026年下半年实现资金自循环，不再依赖外部资本注入。这一里程碑式的进展源于Verastem在临床开发与市场布局方面的双重突破。分析师指出，若该时间表如期实现，Verastem将成为罕见妇科肿瘤领域首个通过单一产品线实现财务独立的生物技术企业。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158797144","title":"Verastem预计2025年第四季度Avmapki Fakzynja联合包装产品净收入约1750万美元，2025年全年约3090万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1158797144","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1158797144?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:33","pubTimestamp":1770208389,"startTime":"0","endTime":"0","summary":"Verastem公司发布预测，其Avmapki Fakzynja联合包装产品在2025年第四季度的净收入预计将达到约1750万美元。同时，该公司对2025年全年的业绩也给出了乐观展望，预计该产品的全年净收入总额约为3090万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145676997","title":"Verastem Oncology 公布2025年第四季度及全年初步营收与业务进展，并规划2026年针对Ras/Mapk通路驱动癌症创新产品组合的战略重点","url":"https://stock-news.laohu8.com/highlight/detail?id=1145676997","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145676997?lang=zh_cn&edition=full","pubTime":"2026-02-04 20:30","pubTimestamp":1770208216,"startTime":"0","endTime":"0","summary":"Verastem Oncology 近日披露了其2025年第四季度及全年的初步营收数据与业务最新动态，同时明确了2026年的核心战略方向，将重点聚焦于针对Ras/Mapk信号通路驱动型癌症的创新药物组合。\n公司概述了未来一年的关键优先事项，旨在加速其新型疗法组合的开发与商业化进程，这些疗法专门设计用于对抗由Ras/Mapk通路异常激活所引发的各类癌症。此次更新突显了公司致力于在该关键肿瘤学领域取得突破性进展的决心。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122401255","title":"Verastem Oncology公布RAMP 203治疗晚期KRAS G12C突变非小细胞肺癌的1/2期临床试验进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1122401255","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122401255?lang=zh_cn&edition=full","pubTime":"2025-12-30 05:02","pubTimestamp":1767042143,"startTime":"0","endTime":"0","summary":"Verastem Oncology近日针对其RAMP 203 1/2期临床试验发布了最新动态。该试验主要聚焦于晚期携带KRAS G12C突变的非小细胞肺癌患者的治疗方案评估。此次更新涉及临床试验的具体推进情况与相关数据，为后续研发路径提供重要参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518220886","title":"Verastem, Inc.盘中异动 大幅上涨5.14%报7.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220886","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518220886?lang=zh_cn&edition=full","pubTime":"2025-03-11 00:49","pubTimestamp":1741625371,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日00时49分，Verastem, Inc.股票出现异动，股价快速拉升5.14%。截至发稿，该股报7.36美元/股，成交量51.1809万股，换手率1.15%，振幅7.43%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004931abf344c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250311004931abf344c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513211811","title":"Verastem, Inc.盘中异动 股价大涨5.21%报5.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513211811","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513211811?lang=zh_cn&edition=full","pubTime":"2025-02-22 03:23","pubTimestamp":1740165786,"startTime":"0","endTime":"0","summary":"北京时间2025年02月22日03时23分，Verastem, Inc.股票出现异动，股价急速拉升5.21%。截至发稿，该股报5.86美元/股，成交量28.4278万股，换手率0.64%，振幅4.94%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.49%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222032306abd7ea85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250222032306abd7ea85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512231196","title":"Verastem, Inc.盘中异动 大幅下挫5.03%报5.67美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512231196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512231196?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:09","pubTimestamp":1739905785,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时09分，Verastem, Inc.股票出现波动，股价急速下挫5.03%。截至发稿，该股报5.67美元/股，成交量30.2897万股，换手率0.68%，振幅5.53%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.90%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030945a24ae609&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219030945a24ae609&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510891292","title":"Verastem, Inc.盘中异动 下午盘大幅下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510891292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510891292?lang=zh_cn&edition=full","pubTime":"2025-02-11 03:28","pubTimestamp":1739215689,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日03时28分，Verastem, Inc.股票出现波动，股价大幅下挫5.01%。Verastem, Inc.股票所在的生物技术行业中，整体跌幅为0.88%。其相关个股中，Dominari Holdings Inc.、Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为3139.85%、1672.88%、1411.40%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Biodexa Pharmaceuticals Plc、Abpro Holdings Inc C/Wts 12/11/2029 ，振幅分别为99.86%、92.63%、87.80%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211032809a240deb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211032809a240deb8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508993691","title":"B. Riley Securities：维持Verastem(VSTM.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至9.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2508993691","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508993691?lang=zh_cn&edition=full","pubTime":"2025-02-01 01:39","pubTimestamp":1738345141,"startTime":"0","endTime":"0","summary":"B. Riley Securities：维持Verastem(VSTM.US)评级，由买入调整至买入评级, 目标价由7.00美元调整至9.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/01013947922571.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506025203","title":"Verastem, Inc.盘中异动 早盘股价大跌5.07%报5.62美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506025203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506025203?lang=zh_cn&edition=full","pubTime":"2025-01-28 00:25","pubTimestamp":1737995148,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日00时25分，Verastem, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报5.62美元/股，成交量40.5328万股，换手率0.91%，振幅7.26%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280025489874c27b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280025489874c27b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505271147","title":"Verastem, Inc.盘中异动 股价大涨6.75%报5.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505271147","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505271147?lang=zh_cn&edition=full","pubTime":"2025-01-21 22:36","pubTimestamp":1737470169,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日22时36分，Verastem, Inc.股票出现波动，股价大幅上涨6.75%。截至发稿，该股报5.69美元/股，成交量3.997万股，换手率0.09%，振幅3.56%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.95%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223609abb34811&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121223609abb34811&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503885623","title":"Verastem, Inc.盘中异动 大幅上涨5.93%报5.34美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503885623","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503885623?lang=zh_cn&edition=full","pubTime":"2025-01-15 22:31","pubTimestamp":1736951519,"startTime":"0","endTime":"0","summary":"北京时间2025年01月15日22时31分，Verastem, Inc.股票出现波动，股价快速上涨5.93%。截至发稿，该股报5.34美元/股，成交量1.411万股，换手率0.03%，振幅0.89%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232009604b3f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501152232009604b3f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VSTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503257929","title":"Verastem, Inc.盘中异动 早盘股价大涨5.81%报5.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503257929","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503257929?lang=zh_cn&edition=full","pubTime":"2025-01-14 22:37","pubTimestamp":1736865450,"startTime":"0","endTime":"0","summary":"北京时间2025年01月14日22时37分，Verastem, Inc.股票出现波动，股价大幅拉升5.81%。截至发稿，该股报5.65美元/股，成交量3.8355万股，换手率0.09%，振幅2.02%。Verastem, Inc.股票所在的生物技术行业中，整体跌幅为0.19%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223730a221b9fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250114223730a221b9fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503588209","title":"Verastem, Inc.盘中异动 早盘快速上涨5.05%报6.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503588209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503588209?lang=zh_cn&edition=full","pubTime":"2025-01-13 22:32","pubTimestamp":1736778752,"startTime":"0","endTime":"0","summary":"北京时间2025年01月13日22时32分，Verastem, Inc.股票出现波动，股价大幅拉升5.05%。截至发稿，该股报6.02美元/股，成交量8.8135万股，换手率0.20%，振幅3.66%。Verastem, Inc.股票所在的生物技术行业中，整体跌幅为0.89%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223232aba930e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250113223232aba930e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501774856","title":"Verastem, Inc.盘中异动 股价大跌5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2501774856","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501774856?lang=zh_cn&edition=full","pubTime":"2025-01-08 22:52","pubTimestamp":1736347979,"startTime":"0","endTime":"0","summary":"北京时间2025年01月08日22时52分，Verastem, Inc.股票出现波动，股价快速跳水5.96%。Verastem, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。其相关个股中，Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大，Silo Pharma, Inc.、60 Degrees Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为1901.08%、546.93%、519.34%，振幅较大的相关个股有Silo Pharma, Inc.、Sana Biotechnology, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为135.78%、109.09%、68.53%。Verastem, Inc.公司简介：Verastem Inc 是一家后期开发生物制药公司，致力于为抗癌患者开发新药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822525995fd036e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025010822525995fd036e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VSTM","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2501786843","title":"加拿大皇家银行：维持Verastem(VSTM.US)评级，由优于大市调整至优于大市评级, 目标价由13.00美元调整至16.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2501786843","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501786843?lang=zh_cn&edition=full","pubTime":"2025-01-07 23:33","pubTimestamp":1736264038,"startTime":"0","endTime":"0","summary":"加拿大皇家银行：维持Verastem(VSTM.US)评级，由优于大市调整至优于大市评级, 目标价由13.00美元调整至16.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/07233347233355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["VSTM"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.verastem.com","stockEarnings":[{"period":"1week","weight":-0.127},{"period":"1month","weight":-0.3526},{"period":"3month","weight":-0.273},{"period":"6month","weight":-0.5405},{"period":"1year","weight":-0.4387},{"period":"ytd","weight":-0.4482}],"compareEarnings":[{"period":"1week","weight":-0.0009},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.0817},{"period":"6month","weight":0.1147},{"period":"1year","weight":0.2431},{"period":"ytd","weight":0.0832}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Verastem, Inc.于2010年8月4日注册成立为一家特拉华州公司。该公司是一家处于后期开发阶段的生物制药公司，正在进行注册定向试验，致力于为与癌症作斗争的患者推进新药。该公司的管道专注于抑制癌症中关键信号通路的新型抗癌剂，这些信号通路可促进癌细胞存活和肿瘤生长，特别是RAF/MEK抑制和FAK抑制。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.073347},{"month":2,"riseRate":0.4,"avgChangeRate":-0.007088},{"month":3,"riseRate":0.466667,"avgChangeRate":0.082917},{"month":4,"riseRate":0.466667,"avgChangeRate":-0.020958},{"month":5,"riseRate":0.466667,"avgChangeRate":0.063864},{"month":6,"riseRate":0.357143,"avgChangeRate":-0.045334},{"month":7,"riseRate":0.428571,"avgChangeRate":0.074115},{"month":8,"riseRate":0.357143,"avgChangeRate":0.01437},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.072546},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.101891},{"month":11,"riseRate":0.785714,"avgChangeRate":0.131906},{"month":12,"riseRate":0.285714,"avgChangeRate":-0.064523}],"exchange":"NASDAQ","name":"Verastem","nameEN":"Verastem"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Verastem(VSTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Verastem(VSTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Verastem,VSTM,Verastem股票,Verastem股票老虎,Verastem股票老虎国际,Verastem行情,Verastem股票行情,Verastem股价,Verastem股市,Verastem股票价格,Verastem股票交易,Verastem股票购买,Verastem股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Verastem(VSTM)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Verastem(VSTM)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}